scholarly article | Q13442814 |
P2093 | author name string | Hao Zhao | |
Jingxian Liu | |||
Jie He | |||
Kaitai Yao | |||
Dengke Li | |||
Jinghong Yang | |||
Zhaohui Wu | |||
Bingtao Hao | |||
Zhongxi Huang | |||
Zhenwei Zhu | |||
Xidong Ye | |||
Yuhe Hou | |||
P2860 | cites work | Casticin inhibits esophageal cancer cell proliferation and promotes apoptosis by regulating mitochondrial apoptotic and JNK signaling pathways | Q93196438 |
Eyes wide open: a critical review of sphere-formation as an assay for stem cells | Q24631827 | ||
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition | Q28118735 | ||
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting | Q35260766 | ||
Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer. | Q37325872 | ||
Casticin induces apoptosis and G0/G1 cell cycle arrest in gallbladder cancer cells | Q37566555 | ||
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer | Q37605004 | ||
Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation | Q38846287 | ||
Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma | Q38928655 | ||
Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line | Q38984431 | ||
Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog). | Q39221235 | ||
Casticin induces leukemic cell death through apoptosis and mitotic catastrophe | Q39896019 | ||
The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action | Q40334843 | ||
Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC). | Q40809231 | ||
Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma | Q41838545 | ||
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. | Q44655988 | ||
In silico analysis and molecular docking study of angiotensin I-converting enzyme inhibitory peptides from smooth-hound viscera protein hydrolysates fractionated by ultrafiltration | Q47853791 | ||
CB002, a novel p53 tumor suppressor pathway-restoring small molecule induces tumor cell death through the pro-apoptotic protein NOXA. | Q48022098 | ||
A novel three-dimensional tumorsphere culture system for the efficient and low-cost enrichment of cancer stem cells with natural polymers | Q49497480 | ||
Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade | Q64109917 | ||
Identify the Key Active Ingredients and Pharmacological Mechanisms of Compound XiongShao Capsule in Treating Diabetic Peripheral Neuropathy by Network Pharmacology Approach. | Q64891661 | ||
Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials | Q83915103 | ||
LigandScout Remote: A New User-Friendly Interface for HPC and Cloud Resources | Q90425694 | ||
Rhein from Rheum rhabarbarum Inhibits Hydrogen-Peroxide-Induced Oxidative Stress in Intestinal Epithelial Cells Partly through PI3K/Akt-Mediated Nrf2/HO-1 Pathways | Q91700978 | ||
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an omic approach to identify novel druggable targets | Q91906540 | ||
High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands | Q92360181 | ||
Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis | Q92946158 | ||
Large-Scale Target Identification of Herbal Medicine Using a Reverse Docking Approach | Q92946244 | ||
Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis | Q93080951 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P304 | page(s) | 348 | |
P577 | publication date | 2019-12-21 | |
P1433 | published in | Cancer Cell International | Q1829859 |
P1476 | title | Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase | |
P478 | volume | 19 |
Q90362265 | An Overview of the Potential Antineoplastic Effects of Casticin | cites work | P2860 |
Search more.